Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 97 | 137 | 648 | 658 |
| Gross Profit | N/A | 97 | 137 | 648 | 658 |
| Operating Expenses | 9,998 | 13,973 | 16,838 | 16,062 | 21,471 |
| Operating Income | -9,998 | -13,875 | -16,701 | -15,414 | -20,812 |
| Other Income | -262 | 11,699 | -437 | -651 | 12,200 |
| Pre-tax Income | -10,261 | -2,176 | -17,138 | -16,065 | -8,612 |
| Net Income Continuous | -10,261 | -2,176 | -17,138 | -16,065 | -8,612 |
| Net Income | $-10,261 | $-2,176 | $-17,138 | $-16,065 | $-8,612 |
| EPS Basic Total Ops | -1.84 | -0.60 | -4.50 | -4.20 | -1.20 |
| EPS Basic Continuous Ops | -2.05 | -0.52 | -4.42 | -4.15 | -1.62 |
| EPS Diluted Total Ops | -1.84 | -0.60 | -4.50 | -4.20 | -1.20 |
| EPS Diluted Continuous Ops | -2.05 | -0.52 | -4.42 | -4.15 | -1.62 |
| EBITDA(a) | $-9,192 | $-12,986 | $-15,953 | $-14,820 | $-20,210 |